Iron pills may weaken immune defenses in rare disease, study investigates
NCT ID NCT07111598
Summary
This study aims to understand how iron deficiency and the iron supplements used to treat it affect the immune system in people with Hereditary Haemorrhagic Telangiectasia (HHT), a rare genetic disorder. Researchers will compare immune cell levels in three groups of adult HHT patients: those with normal iron levels, those taking iron supplements, and those with low iron not yet on supplements. The goal is to learn if low iron or the iron treatment itself is linked to lower immune cell counts seen in this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HAEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Femme-Mère-Enfant
RECRUITINGBron, Rhone, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.